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Abstract
Purpose: Resilience is the ability of individuals to adapt positively in the face of trauma. Little is known, however, about
lifetime factors affecting resilience.
Methods: We assessed the effects of psychiatric disorder and lifetime trauma history on the resilience self-evaluation using
the Connor-Davidson Resilience Scale (CD-RISC-10) in a high-risk-women sample. Two hundred and thirty eight community-
dwelling women, including 122 participants in a study of breast cancer survivors and 116 participants without previous
history of cancer completed the CD-RISC-10. Lifetime psychiatric symptoms were assessed retrospectively using two
standardized psychiatric examinations (Mini International Neuropsychiatric Interview and Watson’s Post-Traumatic Stress
Disorder Inventory).
Results: Multivariate logistic regression adjusted for age, education, trauma history, cancer, current psychiatric diagnoses,
and psychoactive treatment indicated a negative association between current psychiatric disorder and high resilience
compared to low resilience level (OR=0.44, 95% CI [0.21–0.93]). This was related to anxiety and not mood disorder. A
positive and independent association with a trauma history was also observed (OR=3.18, 95% CI [1.44–7.01]).
Conclusion: Self-evaluation of resilience is influenced by both current anxiety disorder and trauma history. The independent
positive association between resilience and trauma exposure may indicate a ‘‘vaccination’’ effect. This finding need to be
taken into account in future studies evaluating resilience in general or clinical populations.
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Introduction
The concept of resilience has been defined as the capacity of
individuals to cope with traumatic events, namely the capacity to
‘‘maintain relatively stable, healthy levels of psychological and
physical functioning (…) as well as the capacity for generative
experiences and positive emotions’’ [1]. While some authors have
argued that resilience cannot be directly measured but only
inferred from the study of both risk factors and positive adaptation
following an adverse life event, [2,3], others have proposed
quantification of resilience using specific scales [4]. Among the
scales developed to explore resilience in adults, two types of
instruments have been used. The first one measures a subject’s
self-evaluation of prior experience in successfully overcoming
stressful events and positive changes. In this case the resilience
evaluation requires the presence of a stressor or a research
participant’s recollection of their response to a previous one. The
second group measures subjective factors, which are considered as
determinants of resilience (e.g. personal competence or social
resources) and may prospectively determine resilience but does not
evaluate resilience itself [5].
Of the first group instruments measuring resilience, the Connor-
Davidson Resilience Scale (CD-RISC) is a self-administered scale
of 25 items that exhibits good psychometric properties [6]. It was
designed to be widely applicable to different populations
establishing norms for resilience in normal and clinical samples,
and to assess the extent to which resilience scores can change in
response to treatment [6]. CD-RISC was initially considered to be
multidimensional, with five factors corresponding to personal
competence/tenacity, trust in one’s instincts/tolerance of negative
affect, positive acceptance of change/secure relationships, control,
and spirituality [6]. However further studies across independent
samples of different ages and cultures has revealed instability in the
factor structure [7,8,9,10] leading to the validation of an abridged
10-items version, the CD-RISC-10. The retained 10 items reflect
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39879the ability to bounce back from the variety of challenges that can
arise in life [11]. This unidimensional version has equally excellent
psychometric properties as the longer version, is applicable for
different cultures and is quite adapted to large epidemiological
studies [11,12,13].
In a sample of 132 students, Campbell-Sills et al. have shown
that regardless the CD-RISC version (complete or abridged)
resilience was associated with personality dimensions such as
neuroticism or extraversion as well as coping styles [11,14]. The
main relevance of these studies is that authors have attempted ‘‘to
capture the essence of resilience’’ showing that resilience scores
could moderate the relationship between childhood emotional
neglect and current psychiatric symptoms [11,14]. More recently a
similar observation was reproduced in a highly traumatized, at
risk, urban population (median age 36 years, predominantly
African American). The authors showed that childhood abuse or
later traumas of adult life contributed to current depressive
symptoms severity while resilience mitigated it [15]. In all these
cross-sectional studies, the authors have implicitly considered
resilience as a personality trait, assuming that high resilience score
lead to fewer psychiatric symptoms in individuals. It is however,
also conceivable that psychiatric symptoms can cause these
persons to evaluate themselves as less resilient [14]. Thus the
nature of the relationship between resilience score and current
psychiatric symptoms in adults remains to be specified. Likewise
the impact of past psychiatric diagnoses on resilience score is
largely unknown. In addition research undertaken in general
populations with the CD-RISC is based on the assumption that
resilience is observed independently of the level of the stress
exposure. Past traumatic events may affect the development of
post-traumatic symptoms following an adverse life event and thus
positive adaptation/resilience [16]. However the impact of
previous trauma on self-evaluation of resilience in the face of
current moderate levels of stress is largely unknown.
Given the increasing interest of psychiatric research in the
relative capacity for healthy adaptation to life adversities as well as
the clinical relevance of resilience measure [6], this retrospective
epidemiological study aims to evaluate resilience in a high-risk
women sample, using the abridged version of the CD-RISC,
taking into account life-time history of trauma (distinguishing
personal from non-personal events), socio-demographic charac-
teristics and lifetime mental health.
Methods
Ethics statement
Ethics approval for the study was given by the national ethics
committee of the National Institute of Health and Medical
Research (Inserm, France). Written informed consent was
obtained from all participants involved in the study.
Participants
The data were derived from a comparative study of breast
cancer survivors and women without previous history of cancer in
which we have previously observed a contrasted pattern of current
psychiatric disorder [17].
Briefly, women were recruited between November 2002 and
April 2004 in waiting rooms of specialist breast radiologists as well
as in the Regional Cancer Hospital Val d’Aurelle-Paul Lamarque
in Montpellier, France. The inclusion conditions were being aged
from 18 to 75 years and having a mammography. The women in
the cancer group had received a primary breast cancer diagnosis
(stage I–III [18]) one to three years before the interview and were
in remission but with no active treatment (except for hormonal
treatment). All the women were interviewed after their mammo-
gram was taken. The standardized interview included resilience
and mental health measures as well as questions on socio-
demographic, lifestyle characteristics and current medications.
Psychoactive treatment consisted of antidepressant and anxiolytic
medications. Of the 324 participants, only women with a complete
psychiatric evaluation and no missing data for the variables
considered in the analysis were included. The present analysis was
thus conducted on 238 participants (122 exposed to breast cancer
and 116 non-exposed). These women did not differ from those
excluded from the analysis with regard to age (p=0.10), marital
status (p=0.10) and education (p=0.22).
Resilience measure
The original CD-RISC is a 25-item scale assessing resilience
during the last month, with higher scores indicating higher
resilience capacity. Each item is rated on a 5-point range of
responses from not true at all (0) to true nearly all time (4). The
total score ranges from 0–100. A preliminary study of its
psychometric properties in general population and patient samples
showed adequate internal consistency, test-retest reliability, and
convergent and divergent validity [6]. The abridged CD-RISC-10
version reflects the ability to tolerate experiences such as change,
personal problems, illness, pressure, failure and painful feeling
(item’s examples: ‘‘Able to adapt to change’’, ‘‘Tend to bounce
back after illness or hardship’’, and ‘‘Can stay focused under
pressure’’). In our sample, the CD-RISC-10 showed high internal
consistency (Cronbach’s a=0.88). Due to non normal distribu-
tion, total scores were categorized into tertiles to examine possible
non-linear association.
Mental health measures
The Watson’s PTSD Interview (PTSD-I, DSM-IIIR; internal
consistency, a=0.92 and test-retest reliability total score=0.95)
[19] was used to obtain both lifetime and current diagnoses of
post-traumatic stress disorder (PTSD), using the validated French
hetero-questionnaire version [20,21]. The first question identifies
past traumatic events spontaneously evoked by the participants. At
this step the nurse specified the question listing a large number of
traumatic events. The second question, concerning the most
frightening personal experience in the past, was only asked if there
was no response to the first question. If this experience is a
traumatic event as defined according to DSM-IV criteria, the
questionnaire is continued focusing on the most traumatic event.
This questionnaire thus lists all past traumatic events declared by
the participants, including cancer when reported as such. The last
part of the PTSD-I then includes 17 items corresponding to
specific DSM-IIIR symptoms. Participants answer each question
using a 7-point Likert scale ranging from ‘‘1 (never)’’ to ‘‘7
(extremely)’’, a score of ‘‘4=commonly’’ being considered to be
sufficient to meet the relevant DSM symptom criterion. The main
advantage of PTSD-I is to provide continuous measures of the
severity of the disorder for every symptom. This assessment tool
also allows measuring partial PTSD, defined as endorsing
symptoms sufficient to meet criteria for two of three PTSD
symptom clusters [22].
A validated standardized psychiatric interview, the Mini
International Neuropsychiatric Interview (MINI; DSM-IV crite-
ria; French version 5.00) was used to investigate dysthymia and
lifetime major depressive disorder (MDD), mania, and anxiety
disorders, e.g. phobia, general anxiety disorder (GAD), obsessive-
compulsive disorder, panic disorder with and without agoraphobia
[23]. Case-level of current mood disorder was defined as a MINI
diagnosis of current MDD, or current mania or current dysthymic
Anxiety and Trauma Exposure in Resilience
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nurse trained by a psychiatrist.
The General Health Questionnaire 28 (GHQ-28) is a self-
administered screening test designed to detect current non-
psychotic psychiatric disorder in community settings [24].
Participants were asked to assess their state in recent weeks
compared to their usual state. This scale consists of four sub-scales
for somatic symptoms, anxiety and insomnia, social dysfunction
and severe depression. It comprises seven positive and 21 negative
items with a total score ranging from 0 to 28 (high level of current
disorder). In our sample the median score, was chosen as a cut-off.
Statistical analysis
Comparisons of the socio-demographic variables between
groups were carried out using the Chi-square test for categorical
variables and Wilcoxon’s test for quantitative variables. Due to
non normal distribution of the resilience scores in our women
sample, multinomial logistic regression models were used to study
the association between CD-RISC-10 scores categorized as tertile
groups with low (reference=R1), intermediate (R2) and high (R3)
resilience level-and current and past mental health, or life-time
serious event exposure. A multivariate logistic regression included
covariates that were commonly reported in the literature (age,
education level) [25,26] or found to be associated with the level of
resilience in our sample at p,0.10 (history of lifetime trauma and
breast cancer, current psychiatric disorder, and psychoactive
treatment). SAS version 9.1 was used for the statistical analyses
with a significance level of p,0.05 (SAS Institute, Inc., North
Carolina).
Results
Resilience according to sample characteristics
In this female sample the median score (Q25–Q75) on the CD-
RISC-10 was 27 (range 22–32). Marital status, age and education
level were not significantly associated with resilience level (Table 1).
Table 2 shows resilience levels as a function of lifetime
psychiatric health and history of exposure to a serious traumatic
event. Women scoring high on the CD-RISC-10 (group R3)
tended having lower risk of current psychiatric disorder (p=0.07).
Higher resilience was associated with less anxiety disorder
(p=0.02), notably GAD (p=0.04). There was no significant
association between resilience level and current mood disorders
including MDD. A similar pattern was observed for women
showing an intermediate resilience level (group R2) except that
they were also at lower risk of current mood disorder (p=0.05).
No significant differences were observed between R2 and R3
groups. Finally, no significant association was observed between
resilience levels and past psychiatric diagnoses.
Regarding lifetime serious events evaluated using the PTSD-I,
two groups were successively considered in the analysis i) ‘‘having
experienced a traumatic event’’ (any type; n=81) and ii) ‘‘having
experienced an early breast cancer but no trauma’’ (n=65). The
most common traumatic events in the first group were the sudden
unexpected death of a close one (n=35; 4 of whom were aged
12 years or younger and 3 were aged 13 to 18 years) and the
cancer disease (n=30) (Table 3). In the subsample of cancer
survivors (n=122), 30 women reported the cancer disease as a
traumatic event and 27 reported another traumatic event, whereas
in the subsample of women without a history of cancer disease
(n=116), 24 women reported a lifetime traumatic event.
Compared to women with low resilience levels, women scoring
at an intermediary level were significantly more likely to have been
exposed to recent breast cancer or a lifetime traumatic event by
more than 2-fold. A similar pattern was observed for the women
scoring at a high resilience level, although the association with a
history of breast cancer failed to be significant (p=0.13) (Table 2).
Figure 1 shows the distribution of women among resilience
groups as a function of lifetime trauma and current psychiatric
disorder. The women without psychiatric disorder and reporting
no lifetime trauma were distributed equally among the three
groups, whereas those having experienced a trauma were more
frequently distributed in the high than in the low resilience group.
For women with current psychiatric disorder an inverse pattern
was observed, only women without lifetime trauma distributed
unequally among groups, being more frequently in the low
resilience group.
Multivariate analyses of factors associated with resilience
In multi-adjusted model current psychiatric disorder and past
trauma remained significantly and independently associated with
resilience level (Table 4). Women with intermediary and high
resilience levels were more likely to report a lifetime trauma
(OR=2.38 and 3.18, respectively). History of breast cancer was
also associated with resilience for the intermediary group although
this failed to be significant in the high resilience group. Current
psychiatric disorders were 2.3 and 3.3 less frequent in the groups
with high and intermediary resilience levels, respectively.
Among the 75 women with current psychiatric disorder, 32
have pure anxiety disorder, 19 pure mood disorder and 24
comorbid anxiety and mood disorder. Women with high resilience
compared to those with low resilience reported 5-fold less current
anxious and depressive comorbidity (OR=0.21, 95%CI [0.06–
0.73], p=0.01) and tended to be at 3-fold lower risk of pure
current anxious disorder (OR=0.37, 95%CI [0.13–1.05],
Table 1. Association between socio-demographic characteristics and resilience level.
CD-RISC-10 score R1 (n=78) R2 (n=76) R3 (n=84)
V a r i a b l e %%%p g l obal
Marital status
Single/widowed/separated 23.08 23.68 23.81 .99
Married/cohabiting 76.92 76.32 76.19
Education . 9years 50.00 52.63 35.71 .07
Median age (Q25-Q75) 53 (46–62) 54 (49–59) 52 (46–60) .68
Note: Resilience scores are classified in three categories: CD-RISC score #23 (R1),23, CD-RISC #29(R2) and CD-RISC score .29 (R3).
doi:10.1371/journal.pone.0039879.t001
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mood disorder (OR=1.01, 95%CI [0.32–3.21], p=0.99).
Discussion
In this sample of adult women the level of resilience measured
with the CD-RISC-10 was negatively associated with the presence
of current psychiatric disorder and positively and independently
associated with previous history of trauma.
Resilience and mental health
Resilience and related concepts such as ‘‘hardiness’’ have been
reported as indices of mental health [27]. The negative association
between current psychiatric diagnoses and resilience has been
Table 2. Association of Lifetime Psychiatric Diagnoses and Lifetime Serious Event Exposure, with Resilience Level.
CD-RISC-10 score
R1
(n=78)
R2
(n=76)
R3
(n=84)
Variable % % %
P
global
OR [95% CI]
(R2 vs.R1) p
OR [95% CI]
(R3 vs.R1) p
Current diagnosis
At least 1 psy.disorder. 42.31 23.68 28.57 .06 0.42 [0.21;0.85] .02 0.55 [0.28;1.05] .07
At least 1 mood disorder
a 23.08 10.67 19.05 .51 0.40 [0.16;0.98] .05 0.79 [0.37;1.67] .53
At least 1 anxious disorder 33.33 21.05 16.67 .01 0.53 [0.26;1.10] .09 0.40 [0.19;0.84] .02
MDD 15.38 7.89 11.90 .49 0.47 [0.17;1.33] .16 0.74 [0.30;1.83] .52
GAD 23.08 10.53 10.71 .02 0.39 [0.16;0.97] .04 0.40 [0.17;0.95] .04
Full or partial PTSD 7.69 11.84 5.95 .69 1.61 [0.54;4.77] .39 0.76 [0.22;2.60] .66
High GHQ28 score
c 58.33 47.22 51.90 .46 0.64 [0.33;1.24] .18 0.77 [0.41;1.47] .43
Psychoactive drug use 35.90 34.21 23.81 .10 0.93 [0.48;1.80] .83 0.56 [0.28;1.11] .09
Past diagnosis
b
At least 1 psy. disorder 25.64 36.84 30.95 .50 1.69 [0.85;3.37] .14 1.30 [0.65;2.59] .45
At least 1 anxious disorder. 11.54 17.11 20.24 .14 1.58 [0.63;3.95] .33 1.94 [0.81;4.66] .14
MDD 30.77 40.79 29.76 .86 1.55 [0.80;3.01] .20 0.95 [0.49;1.87] .89
GAD 14.10 15.79 9.52 .39 1.14 [0.47;2.77] .77 0.64 [0.24;1.69] .37
Serious event history
Trauma 23.08 38.16 40.48 .02 2.06 [1.02;4.15] .04 2.27 [1.14;4.49] .02
Breast cancer event
d 23.08 32.89 26.19 .10 2.65[1.20;5.88] .02 1.83[0.84;4.02] .13
Note: Resilience scores are classified in three categories: CD-RISC score #23 (R1), 23, CD-RISC #29 (R2) and CD-RISC score .29 (R3).
aCurrent mood disorder corresponds to participants who fulfilled criteria for MDD, mania and dysthymic disorder.
bFree of current psychiatric disorder.
cHigh GHQ28 score corresponds to score $median.
dThe analysis was carried out only on the subgroup of women with an history of early breast cancer but no history of traumatic event (n=65).
doi:10.1371/journal.pone.0039879.t002
Table 3. Frequencies of Trauma Categories by Resilience Level in Women who have been exposed to a Lifetime Traumatic Event
(n=81).
CD-RISC-10 score R1 (n=18) R2 (n=29) R3 (n=34)
Trauma category n( % ) n( % ) n( % )
Non-assaultive and personal
Cancer disease 11 (36.7%) 8 (26.7%) 11 (36.7%)
Other life-threatening illness (except cancer) 0 2 0
Natural disaster 020
Discovering a dead body 001
Non-assaultive and non-personal
Sudden, unexpected death of a close one 4 (11.4%) 14 (40.0%) 17 (48.6%)
Serious accident or life-threatening illness of a close one 1 0 3
Assaultive 121
Enable to cite the traumatic event 111
Note: Resilience scores are classified in three categories: CD-RISC score #23 (R1), 23, CD-RISC #29 (R2) and CD-RISC score .29 (R3).
doi:10.1371/journal.pone.0039879.t003
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were reported in psychiatric outpatients and in GAD patients
compared to the general population. In PTSD patients, a greater
global clinical improvement after pharmacologic treatment was
associated with a greater increase in CD-RISC resilience scores
[28]. Our data confirm and extend these findings in non-
psychiatric patients using CD-RISC-10. We did not find a
significant association between past psychiatric diagnoses and
resilience levels, suggesting that global resilience scores could be a
reversible state-like index of mental health as also suggested by two
randomized placebo-controlled trials of antidepressants in Alzhei-
mer’s caregivers and PTSD patients [29,30]. Interestingly, the
association was only significant with current anxiety disorders
(especially GAD), comorbid with mood disorder or not, but not
with mood disorder without anxiety. No previous studies have
examined the relationship between resilience and depressive and
anxious symptomatology simultaneously. In a prospective be-
reavement study, Bonnano observed a large resilient group with a
relatively healthy mental profile prior to the loss, but also a small
group of resilient participants who were highly depressed before
bereavement suggesting that numerous pathways to resilience may
exist, independently of depression. Unfortunately, anxiety was not
examined in this study [1]. The capacity to tolerate high levels of
fear and still perform efficiently within a military context has been
associated with resilience [31] suggesting that low anxiety trait is
associated with resilience. High trait anxiety was also associated
with low hardiness in healthy male participants [32]. Our data
indicate that in women current anxiety disorder is negatively
associated with resilience independently of mood disorder
comorbidity. As in other studies we cannot exclude that
experiencing current anxiety symptoms may lead persons to
perceive themselves as less resilient. This possibility remains to be
clarified, especially in men who are less prone to rumination or
anxiety disorder [33,34].
Resilience and lifetime trauma exposure
The other finding of a positive association between lifetime
traumatic exposure and CD-RISC resilience scores is unexpected
if we refer to some studies in which childhood abuse was shown to
be associated with lower resilience level in adults [35,36]. However
we have already reported that traumatic events could have
negative or positive impact on late-life mental health and suicidal
ideation [37,38] and this may depend on the nature of the trauma
[39]. Interestingly in our sample, the women having recently
experienced the personal trauma of cancer disease were equally
distributed among resilience tertiles as those without trauma. By
contrast, the women having been exposed during the life to the
sudden unexpected death of a close one (i.e. a non personal
trauma) were mainly in the high resilience tertile (46.8%) with only
11.4% in the lowest tertile. One explanation could be that the
exposure to a lifetime trauma and the nature of the trauma may
modify the self-evaluation of resilience for women faced with
current stressful events, possibly because one’s perception of stress
is different according to whether a person was exposed or not to a
trauma, and the degree of exposition. Other possibilities could
involve the recentness of the event ‘‘breast cancer’’ [Mean (SD) =
24.8 months (8.4)] compared to other traumatic events [Mean
(SD) = 273.6 months (206.4)] or age and social support system at
the time of the trauma which was not examined in this study.
Recently Seery et al. have studied the impact of cumulative
lifetime adversity on vulnerability and resilience in a longitudinal
study [40]. Consistent with prior research on the impact of
adversity, they observed linear effects between more lifetime
adversity and higher global distress, functional impairment as well
as lower life satisfaction. However, they also showed that results
yielded quadratic, U-shaped patterns, demonstrating a more
complex relationship between lifetime adversity and outcomes
than previously supposed. Indeed people with a history of some
lifetime adversity (low adversity group) reported better mental
Figure 1. Women’s resilience as a function of lifetime trauma
and current psychiatric disorder.
doi:10.1371/journal.pone.0039879.g001
Table 4. Multivariate Logistic Regression Analyses of Factors
associated with the Level of Resilience.
Variable
OR [95% CI]
(R2 vs.R1) p
OR [95% CI]
(R3 vs.R1) p
Age 1.00 [0.96; 1.03] .92 0.98 [0.95; 1.02] .33
Education.9 years 1.12 [0.56; 2.23] .75 0.47 [0.24; 0.94] .03
History of lifetime
traumatic event
2.38 [1.07; 5.32] .03 3.18 [1.44; 7.01] .004
History of breast cancer 2.03 [1.00; 4.09] .05 1.53 [0.77; 3.06] .23
At least 1 current
psychiatric disorder
0.30 [0.14; 0.67] .003 0.44 [0.21; 0.93] .03
Psychoactive treatment 0.99 [0.47; 2.11] .99 0.51 [0.24; 1.10] .09
Resilience scores are classified in three categories: CD-RISC score #23 (R1), 23,
CD-RISC #29 (R2) and CD-RISC score .29 (R3).
doi:10.1371/journal.pone.0039879.t004
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history of adversity but also than people with no history of
adversity. Actually people with some prior lifetime adversity were
the least affected by recent adverse events. [40]. In our study
despite different outcome measures (e.g. ‘‘resilience’’ versus ‘‘life
satisfaction’’) our data may thus suggest that women with
intermediary (R2) and higher (R3) resilience scores could
correspond to the low adversity group, whereas the high adversity
group would be not represented in our sample. Since all the
lifetime serious events have not been exhaustively collected in this
study, we cannot confirm this hypothesis.
The observation of higher global distress and lower life
satisfaction in people with no history of adversity compared to
people with history of low adversity [40] could relate to the
concept of ‘‘posttraumatic growth or adversarial growth’’ which
has been reported following a number of traumatic events, e.g.
accidents, disasters, cancer, and sexual [41,42]. Adversarial growth
refers to when the process of coping with adversity leads to higher
levels of psychological functioning and well-being than previously
experienced. This concept includes several dimensions, e.g. an
enhancement of the relationships with relatives, a change of the
views of oneself (for example a greater sense of personal resilience)
and in life philosophy [41,42]. Being confronted with traumatic
event may elicit a reevaluation of life goals and priorities, such that
individuals emerge with a greater investment in and appreciation
of life, interpersonal relationships, spirituality, and personal
resources.
It is conceivable that in our study, the measure of current
resilience captures both effects, past growth following adversity
and ‘‘pure’’ resilience. The fact that CD-RISC scores change in
(non-resilient) chronic PTSD patients following pharmacological
treatment, suggests that this scale can evaluate resilience but also
recovery abilities [28,30]. Future longitudinal studies in different
samples focusing on the effect of trauma exposure on resilience
evaluation and growth following adversity are required to explore
this question.
Our study has been conducted on a particularly interesting
sample with approximately the same proportion of women having
directly experienced a trauma (personal trauma, predominantly
cancer disease) and women having learned a deadly trauma of a
relative (non personal trauma). The average resilience score of the
whole sample as measured with the CD-RISC-10 [median (Q25–
Q75) =27.0 (22–32)] appears lower than that described in a large
US population survey [mean (SD) =31.8 (5.4)] [35] but similar to
that described in a Spanish sample of young adults [mean (SD)
=27.4 (6.4)] [12]. The difference in the resilience score could be
due to the nature of the trauma and to gender, women having
lower resilience levels [12,35,43]. No significant association was
found between cancer history and high resilience level whereas
lifetime trauma was strongly and significantly associated with high
resilience level (OR=3.18, p=0.004). This suggests that this
association was more likely related to the traumatic situation
surrounding breast cancer (reported by 24.6% of breast cancer
survivors) rather than breast cancer itself. A positive association
was however still between ‘‘history of breast cancer’’ and the group
of intermediate resilience level, compared to low resilience level.
As women with a breast cancer history have been described to
report high growth in response to adversity [44,45], this may
suggest that this dimension could be more predominant on the
resilience measure in the intermediate than in the high resilience
level group.
Limitations and strengths
Some limitations concern survival and self-reported covariates
with eventual subsequent recall bias, particularly for childhood
trauma. Indeed traumatic life events were gathered using the
Watson’s PTSD Interview and the traumatic history was not
weighted according to number or age at the trauma. As in any
observational study the retrospective collection of lifetime traumas
precludes definitive conclusion about causation.
This study was conducted on a particular sample (adult women
with specific traumatism, 80% of the traumatized women having
declared either a cancer disease, either the sudden, unexpected
death of a close one as traumatic event) which limits the possibility
to generalize to other traumatic events and other population.
The strengths of this study relates to the lifetime mood and
anxiety diagnosis using validated instruments including PTSD
diagnosis which provides a continuous measure of severity and
thus of partial PTSD and the possibility to compare the impact of
personal and non-personal trauma. Furthermore, analyses were
adjusted for psychoactive treatment and socio-demographic
characteristics.
In conclusion, our results stress the need to take into account
current anxiety disorder and the nature of lifetime traumas of
adulthood in resilience studies. Prospective studies in different
samples especially men are required to further specify the
determinants of resilience measured with CD-RISC and its
association with other positive psychological constructs.
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